Geode Capital Management
ZYME icon

Geode Capital Management’s Zymeworks ZYME Stock Holding History

Geode Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.5M Buy
659,940
+11,970
+2% +$283K ﹤0.01% 2099
2025
Q4 		$17.1M Sell
647,970
-30,666
-5% -$669K ﹤0.01% 2100
2025
Q3 		$11.6M Sell
678,636
-26,728
-4% -$383K ﹤0.01% 2331
2025
Q2 		$8.85M Buy
705,364
+329
+0% +$3.92K ﹤0.01% 2440
2025
Q1 		$8.4M Buy
705,035
+15,151
+2% +$207K ﹤0.01% 2400
2024
Q4 		$10.1M Sell
689,884
-24,031
-3% -$336K ﹤0.01% 2367
2024
Q3 		$8.96M Buy
713,915
+965
+0.1% +$10.5K ﹤0.01% 2451
2024
Q2 		$6.07M Buy
712,950
+43,966
+7% +$391K ﹤0.01% 2617
2024
Q1 		$7.04M Buy
668,984
+29,312
+5% +$325K ﹤0.01% 2525
2023
Q4 		$6.65M Buy
639,672
+40,209
+7% +$320K ﹤0.01% 2559
2023
Q3 		$3.8M Buy
599,463
+37,536
+7% +$277K ﹤0.01% 2778
2023
Q2 		$4.86M Buy
561,927
+530,427
+1,684% +$4.75M ﹤0.01% 2691
2023
Q1 		$285K Buy
+31,500
New +$275K ﹤0.01% 3882

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management's ZYME Position: Q1 2026 in Review

Geode Capital Management increased its Zymeworks (ZYME) stake by 1.8% in Q1 2026, buying an estimated $283K and bringing the position to 659,940 shares worth $16.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2099.

Geode Capital Management first reported a position in ZYME in Q1 2023 and has held it in 13 quarters since. The position peaked at $17.1M in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Geode Capital Management held 659,940 shares of Zymeworks worth $16.5M as of Q1 2026.
  • Geode Capital Management bought 11,970 Zymeworks shares in Q1 2026, an estimated $283K.
  • Zymeworks made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2099 holding.
  • Geode Capital Management first reported a position in Zymeworks in Q1 2023 and has held it in 13 quarters since.
  • Geode Capital Management's Zymeworks position peaked at $17.1M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.